answer text |
<p>Like the 2017 Drug Strategy, the forthcoming Drug Strategy has been informed by
extensive consultation with key partners in the drugs field. This includes through
Dame Carol Black’s review of drugs, which involved significant consultation with external
partners to gather information.</p><p>The calls for evidence for parts 1 and 2 of
the review received responses from a wide range of stakeholders, including members
of the public, academics, people working in the substance misuse sector and enforcement
partners. Dame Carol also led an extensive programme of consultation events to develop
her recommendations on drug treatment for part 2 of her review.</p><p>Our Strategy
is responding to Dame Carol Black’s review in full. We have built on the research
undertaken as part of the review, and have continued to consult external experts in
order to shape the approach and interventions set out in the strategy. This includes
Dame Carol Black in her role as independent advisor and Dr Ed Day our national Recovery
Champion. The Advisory Council on the Misuse of Drugs’ Full Council has also been
briefed on our strategic approach and members of the Council have provided feedback.</p>
|
|